Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 proof-of-concept efficacy study for the treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD)

Trial Profile

A Phase 2 proof-of-concept efficacy study for the treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD)

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 20 May 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PUR 1800 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 12 May 2023 According to a Pulmatrix media release, the completed data analysis is expected to inform the study design of this study. company plans to pursue partnership opportunities to advance PUR1800 into a potential this Phase 2 clinical trial.
    • 12 Apr 2021 According to a Pulmatrix media release, this study is not expected to commence until 2022.
    • 19 Feb 2019 According to a Pulmatrix media release, the company expects to initiate CMC development work preparation for this study in 2019.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top